TITLE

The use of pilocarpine in opioid-induced xerostomia

AUTHOR(S)
Mercadante, S.; Calderone, L.; Villari, P.; Serretta, R.; Sapio, M.; Casuccio, A.; Fulfaro, F.
PUB. DATE
November 2000
SOURCE
Palliative Medicine;Nov2000, Vol. 14 Issue 6, p529
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Determines the role of pilocarpine in reducing xerostomia due to opioid used for the management of pain in patients with advanced cancer. Safety and effectiveness of using pilocarpine; Tolerance to opioid-induced xerostomia; Comparison of salivary stimulants versus saliva substitutes.
ACCESSION #
3940983

 

Related Articles

  • Drug laws hurting cancer patients.  // New Scientist;2/27/2010, Vol. 205 Issue 2749, p6 

    The article discusses the impact of the regulation of opioids on Europeans suffering from cancer.

  • The Relationships between Mood Disturbances and Pain, Hope, and Quality of Life in Hospitalized Cancer Patients with Pain on Regularly Scheduled Opioid Analgesic. Utne, Inger; Miaskowski, Christine; Bjordal, Kristin; Paul, Steven M.; Rustoen, Tone // Journal of Palliative Medicine;Mar2010, Vol. 13 Issue 3, p311 

    Objective: The study purposes were to describe the percentage of patients in one of four mood groups (i.e., neither anxiety nor depression [NEITHER], only anxiety [ANX], only depression [DEP], both anxiety and depression [BOTH]) and to evaluate how differences in mood states are related to pain,...

  • Prevalence and Characteristics of Breakthrough Pain in Patients with Head and Neck Cancer: A Cross-Sectional Study. Bhatnagar, Sushma; Upadhyay, Surjya; Mishra, Seema // Journal of Palliative Medicine;Mar2010, Vol. 13 Issue 3, p291 

    Background: Approximately one half to two thirds of patients with cancer-related pain experience breakthrough pain (BTP) in their daily activities. Objective: This is the first report to determine the prevalence and characteristics of BTP experienced by patients with head and neck cancer....

  • Procedimentos intervencionistas para o manejo da dor no câncer. Peixoto Minson, Fabiola; Dias Assis, Fabrício; Vanetti, Thais Kfouri; Sardá Junior, Jamir; Pereira Mateus, Wanessa; Del Giglio, Auro // Einstein (16794508);Jul-Sep2012, Vol. 10 Issue 3, p292 

    Objective: To describe types of interventional medical procedures its rationale use and benefits for a population with cancer assisted at a private hospital in São Paulo. Methods: Quantitative and descriptive cross-sectional study using data from patients submitted to interventional...

  • A systematic review of opioid effects on the hypogonadal axis of cancer patients. McWilliams, Kerry; Simmons, Claribel; Laird, Barry; Fallon, Marie // Supportive Care in Cancer;Jun2014, Vol. 22 Issue 6, p1699 

    Purpose: Opioids are the mainstay of analgesic therapy in patients with cancer-related pain. While many of the side effects of opioids are well documented, the effect on the hypogonadal axis is less well understood. The aim of this systematic review is to examine the relationship between opioid...

  • Fentanyl Effervescent Buccal Tablet. Cada, Dennis J.; Levien, Terri; Baker, Danial E. // Hospital Pharmacy;Mar2007, Vol. 42 Issue 3, p230 

    The article provides information on fentanyl effervescent buccal tablet. It is said that the tablets are indicated for breakthrough pain management in patients with cancer who are already receiving and are tolerant to opioid therapy. Fentanyl is said to be a potent opioid analgesic and produces...

  • Treating cancer pain: Barriers and fears to overcome. Harman, Stephanie M. // Hem/Onc Today;10/10/2011, Vol. 12 Issue 19, p15 

    The article explores the underuse of opioid medications for cancer pain and the strategies to help patients get the relief they need from cancer pain.

  • Tramadol and hyoscine N-butyl bromide combined in infusion solutions: compatibility and stability. Emilia Barcia; Alicia Martín; María Azuara; Yolanda Sánchez; Sofia Negro // Supportive Care in Cancer;Jan2007, Vol. 15 Issue 1, p57 

    Abstract Background?? More than two-thirds of patients with metastatic cancer experience pain. Tramadol is one of the most interesting and useful weak opioids used by palliative care units to treat moderate to moderately severe pain. Relief of distressful symptoms in terminally ill patients is...

  • “Desensitization” of Opioids: A Case Study. Abbas, S. Q. // Journal of Palliative Medicine;Nov2009, Vol. 12 Issue 11, p987 

    The article presents a case study of a cancer patient who was taken to hospice facility due to acute hypersensitivity reaction to opioids. She was treated with radiotherapy, however, she developed adverse reactions. The facility decided to take advice from the Department of Clinical Pharmacology...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics